Radicioni, Milko http://orcid.org/0000-0002-3940-8375
Leuratti, Chiara http://orcid.org/0000-0001-5594-6029
Cometti, Barbara http://orcid.org/0000-0002-0810-7676
Clinical trials referenced in this document:
Documents that mention this clinical trial
Randomized Pharmacokinetic Study of a Highly Purified Human Chorionic Gonadotropin and of a Recombinant Human Chorionic Gonadotropin Following Single Subcutaneous Administration in Healthy Women
https://doi.org/10.1007/s40261-022-01118-w
Article History
Accepted: 12 January 2022
First Online: 9 February 2022
Declarations
:
: The study was funded by IBSA Institut Biochimique S.A., Switzerland.
: B.C. is an employee of IBSA Institut Biochimique S.A., M.R. and C.L. are employees of CROSS Research S.A., Switzerland, which was contracted by IBSA Institut Biochimique S.A. for the conduction of this study and received financial support for its services. The authors declare that they have no other relationships or activities that could appear to have influenced the submitted work.
: The study was approved by the Canton Ticino Ethics Committee, Switzerland, and the Swiss Federal Health Authority, and was performed in accordance with the Helsinki Declaration and Good Clinical Practice.
: All subjects received a detailed study description and gave their written informed consent before enrolment.
: Not applicable.
: The study is registered on Clinicaltrials.gov (no. NCT03735030). The data supporting the study fundings are available from the author (B.C.) upon reasonable request.
: Not applicable.
: All authors made substantial contributions to the conception and design of the study, the acquisition of data, the analysis and interpretation of data, drafting of the article or critical revision for important intellectual content and final approval of the submitted version.